ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Db Xt Ii Ibdl Treasuries 2d

Db Xt Ii Ibdl Treasuries 2d (XUTE)

91.20
0.13
( 0.14% )
Updated: 23:55:31

Professional-Grade Tools, for Individual Investors.

XUTE News

Official News Only
0 articles were found

Discussion

View Full Feed
JRoon71 JRoon71 4 minutes ago
Lizzy, the Share Premium Account is Additional Paid-In Capital.

Per UK law, companies choosing to do a share buyback must use funds from profits. If they are NOT profitable (as with Amarin), if they have excess paid-in capital (share premium account), they may cancel that account and
AMRN
Screech691 Screech691 4 minutes ago
The Water-Less Garden by SGTM: A Game Changer for Dry Climates SGTM's Water-Less Garden is an innovative solution for those living in dry climates or areas with water restrictions. This system uses drought-tolerant plants that require minimal watering, saving water and reducing maintenance costs. Pe
SGTM
Screech691 Screech691 5 minutes ago
Good morning SGTM
SGTM
prototype_101 prototype_101 5 minutes ago
Jeunke, I agree, Lebby with his tiny in-house Device team was trying to accommodate the developments of multiple Tier 1's, "some of the largest Transceiver makers in the world", in putting together custom PIC's for them which was asking way too much in terms of generally assessing the project pieces
LWLG
MartinLutherKing MartinLutherKing 5 minutes ago
Are you referring to the billion dollar news
RNAZ
georgie18 georgie18 5 minutes ago
NKGN...60...🥳...SANTA ANA, Calif., Feb. 21, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer (“NK”) cell thera
NKGN
georgie18 georgie18 5 minutes ago
NKGN...60...🥳...SANTA ANA, Calif., Feb. 21, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer (“NK”) cell thera
NKGN
georgie18 georgie18 6 minutes ago
NKGN...60...🥳...SANTA ANA, Calif., Feb. 21, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer (“NK”) cell thera
NKGN
Topgun21 Topgun21 6 minutes ago
FLOAT here LOCKED!

No dilution!

Trades CLEAN !!

C L E A N !

Shorts TRAPPED!

FLOAT LOCK!

Great leadership, business booming, and STATE OF THE ART MANAGEMENT to deliver SOLID RESULTS!

See you all
STAI
RIGATONI RIGATONI 6 minutes ago
Nice news here again

NKGN .61
https://www.globenewswire.com/news-release/2025/02/21/3030420/0/en/NKGen-Biotech-Announces-Administration-of-First-Dose-of-Troculeucel-to-Frontotemporal-Dementia-Patient-Under-FDA-Cleared-Compassionate-Use-Program.html
NKGN
Chiron Chiron 6 minutes ago
Democracy is so 20th century... this is Trumps country now.
ASII
Trooperstocks Trooperstocks 6 minutes ago
SGTM's YouTube channel serves as an excellent resource for consumers looking to learn more about green alternatives.
https://img1.wsimg.com/isteam/ip/9f8df632-1291-4de6-ae2e-6cd4239755a5/IMG_3539-fd8785c.jpeg/:/cr=t:0%25,l:0%25,w:100%25,h:100%25/rs=w:1280
SGTM
BIOChecker4 BIOChecker4 6 minutes ago
Pogue - Your criticisms of Missling’s speech (and I would add his writing) are spot on. I have been saying this for a decade. However, there are some deeper truths. Among them are: 1) Missling is who he is and he’s clearly not going to change. He is either oblivious to any criticism or doesn’t care.
AVXL
Rodney5 Rodney5 6 minutes ago
You’re exactly right stockanalyze, taking the stops out. We don’t know the mind of the market maker, large institutions, hedge funds, day traders, short sellers etc… in short term run the price up or down depending on which side of the trade whether buying or selling. That’s why it’s imperative to k
FNMA
linkvest linkvest 6 minutes ago
I want that Nickel for waiting a here for a year. I need more fun money...🤑😎
IGPK
The ELTP King The ELTP King 7 minutes ago
Exactly.

As WeeZuhl said, "Nasrat is a mediocre CEO at best."

He’s been ceo since 2013 and we have gone from 9 cents to 50 cents. Big deal.
ELTP
trunkmonk trunkmonk 7 minutes ago
My estimate is for US only, dont matter about the rest of the world, Dollar is king in finance, the rest will follow. Buuut his seems to be more in depth and inclusive than mine, he does analysis with various Money supply calculations. either way gold should be multiples of where it is now without i
GOLD
georgie18 georgie18 7 minutes ago
AIFF...$7.57...🥳...No Position...Watching for another entry...KENMORE, N.Y., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes
AIFF
tw0122 tw0122 7 minutes ago
NKGN .63 added back in .40s beatdown picking up steam at .60s 
NKGN
ksquared ksquared 7 minutes ago
Wow. That's colder than we are. It's a balmy 17° here.
I was outside sweeping snow earlier. Didn't feel all that bad.
Good Morning, Larry. Stay safe and warm.
georgie18 georgie18 8 minutes ago
AIFF...$7.57...🥳...No Position...Watching for another entry...KENMORE, N.Y., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes
AIFF
Topgun21 Topgun21 8 minutes ago
$STAI higher highs, higher lows, FLOAT LOCKED and shorts TRAPPED!
GLTU!
Respectfully,
Maverick
STAI
Semper Fi 88 Semper Fi 88 8 minutes ago
Committee hearing first...full vote is what we are waiting on...with luck in March
FNMA
georgie18 georgie18 8 minutes ago
AIFF...$7.57...🥳...No Position...Watching for another entry...KENMORE, N.Y., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) company developing innovative solutions that improve brain health outcomes
AIFF